Real-World Evaluation of Patient Characteristics and Treatment Patterns Among Patients With CML-CP Treated With Asciminib

Clinical trial NCT06516029 · COMPLETED

Trial details

NCT number: NCT06516029
Sponsor: Novartis
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Myeloid Leukemia, Chronic Phase

Start date: 2023-04-21
Primary completion: 2023-10-02
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.